Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Investments" stands at -1.65 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Amgen Inc's third quarter result of -0.414 Billion USD for the item "Investments" represents a decrease of -6.43 percent compared to it's second quarter result.
Also, Amgen Inc's third quarter result of -0.414 Billion USD for the item "Investments" represents a decrease of -97.14 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of -1.65 Billion USD for the item "Investments" represents a decrease of -14.09 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.08 Billion United States Dollars compared to the value the year prior.
The 1 year change is 26.08 Billion United States Dollars.
The 3 year change is 0.494 Billion United States Dollars.
The 5 year change is -5.70 Billion United States Dollars.
The 10 year change is 2.35 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Investments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Investments | 280,205,508,085.11 |